BFI Finance Indonesia Tbk vs Cipta Sarana Medika Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp915 (market cap 13.76T, 29.96M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 85.6× Cipta Sarana Medika Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (29.96M versus 14.05M). Which is the better fit depends on your goals.
| BFIN | DKHH | |
|---|---|---|
Market Cap | 13.76T | 160.67B |
Volume | 29.96M | 14.05M |
Lot | 299.63K | 140.49K |
Turnover | 27.08B | 899.67M |
Average Price | 903.88 | 64.04 |
Value | 27.08B | 899.67M |
Indicative Equilibrium Price | 915 | 64 |
Indicative Equilibrium Volume | 2.26K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →